By developing the Oncopore G2121, a domestically-produced electrochemotherapy (ECT) system featuring proprietary probe technology with no foreign analogues, Iran has joined the United Kingdom and Italy as one of only three nations worldwide capable of manufacturing this advanced cancer treatment device.